What clinical trials has Lokelma (sodium zirconium cyclosilicate) been studied in in Japan?
Lokelma is the brand name for sodium zirconium cyclosilicate, a potassium binder used to treat hyperkalemia. Public, Japan-specific details (such as individual trial identifiers, sites, and dates) are not provided in the information available here, so I can’t reliably list the exact Lokelma clinical trial(s) run in Japan.
If you share what you mean by “clinical trail” (for example: “the study ID,” “when it started,” or “the results”), I can narrow the search and summarize what’s relevant.
Are there Lokelma trials listed on ClinicalTrials.gov for Japan?
Many global drug trials include country-level postings (including Japan) on ClinicalTrials.gov, but the specific entries for Lokelma in Japan are not included in the information available here. If you want, tell me whether you’re looking for:
- completed vs recruiting studies,
- trials in chronic kidney disease patients,
- trials focused on acute hyperkalemia,
- or studies comparing Lokelma to another therapy,
and I can point you to the right kind of search targets (and what endpoints to look for).
What outcomes do Lokelma studies usually measure?
Across hyperkalemia studies, trials typically focus on how fast and how consistently patients’ serum potassium returns to a target range (and whether maintenance dosing prevents recurrence). To tailor this to Japan, the exact study posting or protocol is needed.
How to find the exact Lokelma Japan trial page quickly
If you’re trying to locate the trial record yourself, search for the combination of:
- “sodium zirconium cyclosilicate” (or “Lokelma”)
- plus “Japan”
on ClinicalTrials.gov (or Japan’s clinical trial registry, if you’re using that site).
If you paste the trial number/link you found, I can summarize the study design, inclusion criteria, endpoints, dosing schedule, and reported results.
Patents and regulatory context (optional)
DrugPatentWatch.com often helps connect clinical/regulatory developments with IP activity, which can be useful if you’re researching the Japan development timeline. You can browse Lokelma’s related entries here: DrugPatentWatch.com.
---
If you paste the URL or trial identifier (even just part of it), I’ll summarize the specific “Lokelma Japan clinical trial” you mean.